BD Names Greg Rodetis as Senior Vice President of Investor Relations
- Greg Rodetis will lead all aspects of communicating BD's strategy to investors and the financial community
- Rodetis has deep knowledge of BD and expertise in capital markets
- Rodetis will serve as a valued partner to stakeholders as BD delivers on its growth strategy
- None.
In this expanded role, Greg will continue as company treasurer and also lead all aspects of communicating progress of BD's strategy to investors and the financial community, including the company's initiatives that drive shareholder value. Rodetis will continue to report to Chris DelOrefice, executive vice president and chief financial officer for BD.
"Greg's deep knowledge of BD, coupled with his expertise of the capital markets and existing relationships with the investment banking community, make him well-positioned to lead our investor relations function and serve as a valued partner to this important stakeholder group as BD continues to deliver on its growth strategy," said DelOrefice.
Rodetis joined BD in 2016 as vice president and assistant treasurer, capital markets. In his current role as treasurer, Rodetis is responsible for leadership and oversight of the company's Treasury function as a strategic partner in supporting business performance, earnings growth and shareholder return. Prior to BD, Greg was with Terex Corporation as the assistant treasurer and prior to this he held roles of progressive responsibility with PepsiCo, Inc., and General Electric Company.
Rodetis holds a Bachelor of Science in Finance from
About BD
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 77,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/ and Twitter @BDandCo.
Media: | Investors: |
Troy Kirkpatrick | Adam Reiffe |
BD Public Relations | BD Investor Relations |
858.617.2361 | 201.847.6927 |
View original content to download multimedia:https://www.prnewswire.com/news-releases/bd-names-greg-rodetis-as-senior-vice-president-of-investor-relations-301958983.html
SOURCE BD (Becton, Dickinson and Company)
FAQ
Who is Greg Rodetis?
What will be Greg Rodetis' new role?
Who will Greg Rodetis report to?
What is BD's growth strategy?
What is Greg Rodetis' educational background?
